IL-12 IMMUNOKONJUGATE

European patent · EP2736535 · In force

Register entry

Publication number
EP2736535
Application number
EP12741305
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 24, 2012
Published
Jun 4, 2014
Granted
Oct 17, 2018
Protection ends at the latest
Jul 23, 2032
Next annual fee due
Jul 31, 2027
IPC classes
A61K 47/68 (2017.01)
A61P 35/00 (2006.01)
A61P 35/04 (2006.01)
C07K 14/54 (2006.01)
Priority
US 201161512190 P 27.07.2011
PCT application
PCT/EP2012/064490 24.07.2012
PCT publication
WO2013/014149 31.01.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  4. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  5. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  6. Jan 16, 2019

    Change

    Published in Swissreg on 16.01.2019

  7. Dec 5, 2018

    Change

    Published in Swissreg on 05.12.2018

  8. Oct 17, 2018

    Granted

    Published in Swissreg on 17.10.2018

Parties

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.